Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Patients treated with immune-checkpoint inhibitors often experience a wide range of peculiar adverse events, called immune-related adverse events (irAEs). Lately, it has been described that the presence of irAEs may be associated with better clinical response to immunotherapy. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Paderi, Agnese, Giorgione, Roberta, Giommoni, Elisa, Mela, Marinella Micol, Rossi, Virginia, Doni, Laura, Minervini, Andrea, Carini, Marco, Pillozzi, Serena, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922597/
https://www.ncbi.nlm.nih.gov/pubmed/33670634
http://dx.doi.org/10.3390/cancers13040860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922597/
https://www.ncbi.nlm.nih.gov/pubmed/33670634
http://dx.doi.org/10.3390/cancers13040860

Ejemplares similares